<HTML>
<HEAD>
<TITLE>WRIGHT MEDICAL GROUP - FORM S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="2">As filed with the Securities and
Exchange Commission on September&nbsp;9, 2003</FONT>

<P align="right"><FONT size="2">Registration No.&nbsp;333-_____</FONT>

<HR size="1" noshade>




<P align="center"><FONT size="4">SECURITIES AND EXCHANGE COMMISSION</FONT>

<DIV align="center"><FONT size="3">Washington, D.C. 20549</FONT></DIV>

<P align="center"><FONT size="5">FORM S-8</FONT>

<DIV align="center"><FONT size="2">REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</FONT></DIV>

<P align="center"><FONT size="6">WRIGHT MEDICAL GROUP, INC.</FONT>

<DIV align="center"><FONT size="2">(Exact name of registrant as specified in its charter)</FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="65%">
<TR valign="bottom">
    <TD width="51%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">Delaware</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
13-4088127</FONT></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">(State or other jurisdiction</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
(I.R.S. Employer</FONT></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><FONT size="2">of incorporation or organization)</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="center" valign="top"><FONT size="2">
Identification Number)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">5677 Airline Road<BR>
Arlington, Tennessee 38002</FONT>

<P align="center"><FONT size="2">(Address, including zip code, of principal executive offices)</FONT>

<HR width="80%" align="center" size="1" noshade>


<DIV align="center"><FONT size="2"><FONT size="3">Wright Medical Group, Inc.<BR>
Second Amended and Restated 1999 Equity Incentive Plan<BR>
(Full title of the plan)</FONT></FONT></DIV>


<HR width="80%" align="center" size="1" noshade>


<DIV align="center"><FONT size="2"><FONT size="3">F. Barry Bays<BR>
President and Chief Executive Officer<BR>
Wright Medical Group, Inc.<BR>
5677 Airline Road<BR>
Arlington, Tennessee 38002<BR>
(901)&nbsp;867-9971<BR>
(Name, address, including zip code, and telephone number, including area code, of agent for service)</FONT></FONT></DIV>


<HR width="80%" align="center" size="1" noshade>


<DIV align="center"><FONT size="2"><FONT size="3">Copy to:<BR>
Rebecca W. Ballou, Esq.<BR>
Baker, Donelson, Bearman, Caldwell &#038; Berkowitz<BR>
165 Madison Avenue, 20th Floor<BR>
Memphis, TN 38103<BR>
(901)&nbsp;526-2000</FONT></FONT></DIV>


<HR width="80%" align="center" size="1" noshade>



<P align="center"><FONT size="2">Calculation of Registration Fee</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="24%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount to be</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed maximum</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Proposed maximum</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>Amount of</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Title of securities</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>registered</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>offering price per</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>aggregate offering</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>registration</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>to be registered</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>(1)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>share (2)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>price (2)</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center" colspan="3"><FONT size="1"><B>fee</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD colspan="3"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">Common Stock</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">
2,000,0000</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">23.34</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">46,680,000</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD nowrap align="right" valign="top"><FONT size="2">$</FONT></TD>
    <TD align="right" valign="top"><FONT size="2">3,776.41</FONT></TD>
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">1.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">This Registration Statement covers 2,000,000 shares of voting common
stock, $0.01 par value per share, of Wright Medical Group, Inc. (the
&#147;Common Stock&#148;) issuable pursuant to the Wright Medical Group, Inc. Second
Amended and Restated 1999 Equity Incentive Plan (the &#147;Plan&#148;). The Plan
authorizes the issuance of a maximum of 6,767,051 shares of Common Stock,
including the 2,000,000 shares being registered hereby. In addition, this
Registration Statement covers an indeterminable number of additional
shares of Common Stock as may hereafter be offered or issued pursuant to
the Plan, to prevent dilution resulting from stock splits or similar
transactions effected without receipt of consideration and pursuant to
Rule&nbsp;416(c) under the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;).</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="1%" align="left" nowrap><FONT size="2">2.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="96%"><FONT size="2">Estimated solely for calculating the amount of the registration fee. The
registration fee has been calculated pursuant to paragraphs (c)&nbsp;and (h)&nbsp;of
Rule&nbsp;457 under the Securities Act based upon the average of the high and
low sales prices of the Common Stock as reported by the Nasdaq National
Market on September&nbsp;4, 2003.</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">&nbsp;</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>



<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART II</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="g84870exv5.txt">EX-5 OPINION OF BAKER DONELSON</A></TD></TR>
<TR><TD colspan="9"><A HREF="g84870exv23w1.txt">EX-23.1 CONSENT OF KPMG LLP</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link1 "PART II" -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="center"><FONT size="2">PART II</FONT>

<P align="center"><FONT size="2">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The stockholders of Wright Medical Group, Inc. (the &#147;Company&#148;) originally
approved the Company&#146;s 1999 Equity Incentive Plan on December&nbsp;7, 1999, and the
plan subsequently was amended and restated on July&nbsp;6, 2001. On May&nbsp;13, 2003,
the Company&#146;s stockholders approved an amendment increasing the number of
shares of Common Stock available for awards thereunder by 2,000,000 shares,
which are the subject of this registration statement.
</FONT>
<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The contents of the Company&#146;s earlier Registration Statement, file number
333-75176, are incorporated herein by reference.
</FONT>
<P align="left"><FONT size="2">ITEM 3. INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</FONT>

<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="6%"></TD>
        <TD width="94%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents, filed with the Securities and
Exchange Commission (the &#147;Commission&#148;) by Wright Medical Group,
Inc., a Delaware corporation (the &#147;Company&#148;), are incorporated by
reference into the Registration Statement:</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">1.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The Company&#146;s Annual Report on Form&nbsp;10-K for the
year ended December&nbsp;31, 2002, filed with the Commission on
March&nbsp;14, 2003;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">2.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K, filed
with the Commission on April&nbsp;28, 2003;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">3.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The Company&#146;s Quarterly Report on Form&nbsp;10-Q for
the quarter ended March&nbsp;31, 2003, filed with the Commission on
May&nbsp;7, 2003;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">4.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The Company&#146;s Current Report on Form&nbsp;8-K, filed
with the Commission on July&nbsp;28, 2003;</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">5.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The Company&#146;s Quarterly Report on Form&nbsp;10-Q for
the quarter ended June&nbsp;30, 2003, filed with the Commission on
August&nbsp;7, 2003; and</FONT></TD>
</TR>
<TR>
        <TD><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR valign="top">
        <TD width="6%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="1%" align="left" nowrap><FONT size="2">6.</FONT></TD>
        <TD width="3%"><FONT size="2">&nbsp;</FONT></TD>
        <TD width="90%"><FONT size="2">The description of the Common Stock contained in
the Prospectus portion of the Company&#146;s Form&nbsp;S-1 (Registration
No.&nbsp;333-81618) filed with the Commission on February&nbsp;28, 2002,
under the heading &#147;Description of Capital Stock.&#148;</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="6%"></TD>
        <TD width="94%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All documents subsequently filed by the Company with the
Commission pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;),
prior to the filing of a post-effective amendment which indicates
that all the securities offered hereby have been sold or which
deregisters all securities then remaining unsold, shall be deemed
to be incorporated by reference in this Registration Statement and
to be a part hereof from the date of the filing of such documents
with the Commission.</FONT></TD>
</TR>
</TABLE>
<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="6%"></TD>
        <TD width="94%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference in this registration
statement the copy of its report dated February&nbsp;22,</FONT></TD>
</TR>
</TABLE>
<P align="center"><FONT size="2">1</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">
<TR>
        <TD width="6%"></TD>
        <TD width="94%"></TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">2002, which is included in the Company&#146;s Annual Report on Form
10-K for the year ended December&nbsp;31, 2002. The absence of such
consent may limit recovery by investors on certain claims,
including without limitation, claims arising under Section&nbsp;11 of
the Securities Act.</FONT></TD>
</TR>
</TABLE>
<P align="left"><FONT size="2">ITEM 4. EXHIBITS</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="86%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Exhibit No.</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Description of Exhibits</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Wright Medical Group, Inc. Second Amended and Restated 1999 Equity
Incentive Plan (incorporated by reference to the Company&#146;s
Definitive Proxy Statement filed with the Commission on April&nbsp;11,
2003).</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Opinion of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. concerning the legality of the securities being registered.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of KPMG LLP.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference a copy of its report dated February
22, 2002. See Item&nbsp;3.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. (included in Exhibit&nbsp;5).</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">24</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Power of Attorney (reference is made to the signature page).</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">2</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="center"><FONT size="2">SIGNATURES</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, the Company certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized on the 8th
day of September, 2003.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
WRIGHT MEDICAL GROUP, INC.</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2"></FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
By: /s/ F. Barry Bays<BR>
</FONT><HR size="1" noshade><FONT size="2">
F. Barry Bays<BR>
President and Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">POWER OF ATTORNEY</FONT>

<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the undersigned officers and directors of Wright Medical Group,
Inc. hereby severally constitutes and appoints John K. Bakewell as the
attorney-in-fact for the undersigned, in any and all capacities, with full
power of substitution, to sign any and all pre- or post-effective amendments to
this Registration Statement, any subsequent Registration Statement for the same
offering which may be filed pursuant to Rule&nbsp;462(b) under the Securities Act of
1933, as amended, and any and all pre- or post-effective amendments thereto,
and to file the same with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as
fully to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact may lawfully do or
cause to be done by virtue hereof.
</FONT>
<P align="left"><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Signature</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Title</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Date</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ F. BARRY BAYS<BR>
</FONT><HR size="1" noshade><FONT size="2">
F. Barry Bays</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
President, Chief Executive<BR>
Officer and Director<BR>
(Principal Executive Officer)<BR>
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ JOHN K. BAKEWELL<BR>
</FONT><HR size="1" noshade><FONT size="2">
John K. Bakewell</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Executive Vice President and<BR>
Chief Financial Officer<br>
(Principal Financial Officer<BR>
and Principal Accounting<BR>
Officer)
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ JAMES T. TREACE<BR>
</FONT><HR size="1" noshade><FONT size="2">
James T. Treace</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Chairman of the Board
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ RICHARD B. EMMITT<BR>
</FONT><HR size="1" noshade><FONT size="2">
Richard B. Emmitt</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">3</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="27%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ JAMES E. THOMAS<BR>
</FONT><HR size="1" noshade><FONT size="2">
James E. Thomas</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ THOMAS E. TIMBIE<BR>
</FONT><HR size="1" noshade><FONT size="2">
Thomas E. Timbie</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">/s/ ELIZABETH H. WEATHERMAN<BR>
</FONT><HR size="1" noshade><FONT size="2">
Elizabeth H. Weatherman</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Director
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">September 8, 2003</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">4</FONT>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="center"><FONT size="2">INDEX TO EXHIBITS</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="75%">
<TR valign="bottom">
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="86%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><FONT size="1"><B>Exhibit No.</B></FONT></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><FONT size="1"><B>Description of Exhibits</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="center"><HR size="1" noshade></TD>
    <TD><FONT size="1">&nbsp;</FONT></TD>
    <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">4</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Wright Medical Group, Inc. Second Amended and Restated 1999 Equity
Incentive Plan (incorporated by reference to the Company&#146;s
Definitive Proxy Statement filed with the Commission on April&nbsp;11,
2003).</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">5</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Opinion of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. concerning the legality of the securities being registered.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.1</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of KPMG LLP.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.2</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference a copy of its report dated February
22, 2002. See Item&nbsp;3.</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">23.3</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Consent of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. (included in Exhibit&nbsp;5).</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><FONT size="2">24</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
Power of Attorney (reference is made to the signature page).</FONT></TD>
</TR>
</TABLE>
</CENTER>

<P align="center"><FONT size="2">5</FONT>




</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g84870sv8.htm", "description": "WRIGHT MEDICAL GROUP - FORM S-8", "secsgml_size_bytes": 31164}]
{"company-data": {"conformed-name": "WRIGHT MEDICAL GROUP INC", "cik": "0001137861", "assigned-sic": "3842", "irs-number": "134088127", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-108638", "film-number": "03888142"}, "business-address": {"street1": "5677 AIRLINE ROAD", "city": "ARLINGTON", "state": "TN", "zip": "38002", "phone": "9018679971"}}
WRIGHT MEDICAL GROUP - FORM S-8
Table of Contents
As filed with the Securities and
Exchange Commission on September 9, 2003
Registration No. 333-_____
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
13-4088127
(State or other jurisdiction
(I.R.S. Employer
of incorporation or organization)
Identification Number)
5677 Airline Road
Arlington, Tennessee 38002
(Address, including zip code, of principal executive offices)
Wright Medical Group, Inc.
Second Amended and Restated 1999 Equity Incentive Plan
(Full title of the plan)
F. Barry Bays
President and Chief Executive Officer
Wright Medical Group, Inc.
5677 Airline Road
Arlington, Tennessee 38002
(901) 867-9971
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to:
Rebecca W. Ballou, Esq.
Baker, Donelson, Bearman, Caldwell & Berkowitz
165 Madison Avenue, 20th Floor
Memphis, TN 38103
(901) 526-2000
Calculation of Registration Fee
Amount to be
Proposed maximum
Proposed maximum
Amount of
Title of securities
registered
offering price per
aggregate offering
registration
to be registered
(1)
share (2)
price (2)
fee
Common Stock
2,000,0000
$
23.34
$
46,680,000
$
3,776.41
1.
This Registration Statement covers 2,000,000 shares of voting common
stock, $0.01 par value per share, of Wright Medical Group, Inc. (the
"Common Stock") issuable pursuant to the Wright Medical Group, Inc. Second
Amended and Restated 1999 Equity Incentive Plan (the "Plan"). The Plan
authorizes the issuance of a maximum of 6,767,051 shares of Common Stock,
including the 2,000,000 shares being registered hereby. In addition, this
Registration Statement covers an indeterminable number of additional
shares of Common Stock as may hereafter be offered or issued pursuant to
the Plan, to prevent dilution resulting from stock splits or similar
transactions effected without receipt of consideration and pursuant to
Rule 416(c) under the Securities Act of 1933, as amended (the "Securities
Act").
2.
Estimated solely for calculating the amount of the registration fee. The
registration fee has been calculated pursuant to paragraphs (c) and (h) of
Rule 457 under the Securities Act based upon the average of the high and
low sales prices of the Common Stock as reported by the Nasdaq National
Market on September 4, 2003.
TABLE OF CONTENTS
PART II
SIGNATURES
INDEX TO EXHIBITS
EX-5 OPINION OF BAKER DONELSON
EX-23.1 CONSENT OF KPMG LLP
Table of Contents
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
The stockholders of Wright Medical Group, Inc. (the "Company") originally
approved the Company's 1999 Equity Incentive Plan on December 7, 1999, and the
plan subsequently was amended and restated on July 6, 2001. On May 13, 2003,
the Company's stockholders approved an amendment increasing the number of
shares of Common Stock available for awards thereunder by 2,000,000 shares,
which are the subject of this registration statement.
The contents of the Company's earlier Registration Statement, file number
333-75176, are incorporated herein by reference.
ITEM 3. INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents, filed with the Securities and
Exchange Commission (the "Commission") by Wright Medical Group,
Inc., a Delaware corporation (the "Company"), are incorporated by
reference into the Registration Statement:
1.
The Company's Annual Report on Form 10-K for the
year ended December 31, 2002, filed with the Commission on
March 14, 2003;
2.
The Company's Current Report on Form 8-K, filed
with the Commission on April 28, 2003;
3.
The Company's Quarterly Report on Form 10-Q for
the quarter ended March 31, 2003, filed with the Commission on
May 7, 2003;
4.
The Company's Current Report on Form 8-K, filed
with the Commission on July 28, 2003;
5.
The Company's Quarterly Report on Form 10-Q for
the quarter ended June 30, 2003, filed with the Commission on
August 7, 2003; and
6.
The description of the Common Stock contained in
the Prospectus portion of the Company's Form S-1 (Registration
No. 333-81618) filed with the Commission on February 28, 2002,
under the heading "Description of Capital Stock."
All documents subsequently filed by the Company with the
Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
prior to the filing of a post-effective amendment which indicates
that all the securities offered hereby have been sold or which
deregisters all securities then remaining unsold, shall be deemed
to be incorporated by reference in this Registration Statement and
to be a part hereof from the date of the filing of such documents
with the Commission.
The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference in this registration
statement the copy of its report dated February 22,
1
Table of Contents
2002, which is included in the Company's Annual Report on Form
10-K for the year ended December 31, 2002. The absence of such
consent may limit recovery by investors on certain claims,
including without limitation, claims arising under Section 11 of
the Securities Act.
ITEM 4. EXHIBITS
Exhibit No.
Description of Exhibits
4
Wright Medical Group, Inc. Second Amended and Restated 1999 Equity
Incentive Plan (incorporated by reference to the Company's
Definitive Proxy Statement filed with the Commission on April 11,
2003).
5
Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. concerning the legality of the securities being registered.
23.1
Consent of KPMG LLP.
23.2
The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference a copy of its report dated February
22, 2002. See Item 3.
23.3
Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. (included in Exhibit 5).
24
Power of Attorney (reference is made to the signature page).
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act, the Company certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized on the 8th
day of September, 2003.
WRIGHT MEDICAL GROUP, INC.
By: /s/ F. Barry Bays
F. Barry Bays
President and Chief Executive Officer
POWER OF ATTORNEY
Each of the undersigned officers and directors of Wright Medical Group,
Inc. hereby severally constitutes and appoints John K. Bakewell as the
attorney-in-fact for the undersigned, in any and all capacities, with full
power of substitution, to sign any and all pre- or post-effective amendments to
this Registration Statement, any subsequent Registration Statement for the same
offering which may be filed pursuant to Rule 462(b) under the Securities Act of
1933, as amended, and any and all pre- or post-effective amendments thereto,
and to file the same with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as
fully to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact may lawfully do or
cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
Signature
Title
Date
/s/ F. BARRY BAYS
F. Barry Bays
President, Chief Executive
Officer and Director
(Principal Executive Officer)
September 8, 2003
/s/ JOHN K. BAKEWELL
John K. Bakewell
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting
Officer)
September 8, 2003
/s/ JAMES T. TREACE
James T. Treace
Chairman of the Board
September 8, 2003
/s/ RICHARD B. EMMITT
Richard B. Emmitt
Director
September 8, 2003
3
Table of Contents
/s/ JAMES E. THOMAS
James E. Thomas
Director
September 8, 2003
/s/ THOMAS E. TIMBIE
Thomas E. Timbie
Director
September 8, 2003
/s/ ELIZABETH H. WEATHERMAN
Elizabeth H. Weatherman
Director
September 8, 2003
4
Table of Contents
INDEX TO EXHIBITS
Exhibit No.
Description of Exhibits
4
Wright Medical Group, Inc. Second Amended and Restated 1999 Equity
Incentive Plan (incorporated by reference to the Company's
Definitive Proxy Statement filed with the Commission on April 11,
2003).
5
Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. concerning the legality of the securities being registered.
23.1
Consent of KPMG LLP.
23.2
The Company was unable to obtain the written consent of Arthur
Andersen LLP to incorporate by reference a copy of its report dated February
22, 2002. See Item 3.
23.3
Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. (included in Exhibit 5).
24
Power of Attorney (reference is made to the signature page).
5